Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 422, 7 (6 March 2003) | doi:10.1038/422007a
Cancer risk prompts US to curb gene therapy
Erika Check
Children with severe combined immunodeficiency disease (SCID) should not normally be treated with gene therapy because of the associated cancer risk, a US advisory panel says. But it believes that there is insufficient evidence to justify halting similar trials for other conditions.
To read this story in full you will need to login or make a payment (see right).